Streptomycin Sulfate
NDC Package 0049-0620-33

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Streptomycin Sulfate is a medication used with other medications to treat active tuberculosis (TB) infection if you cannot take other drugs for TB or if you have a type of TB that cannot be treated with other drugs (drug-resistant TB). Marketed by Roerig, this product is identified by NDC 0049-0620 and is authorized under FDA application ANDA060111.

Identification & Billing

NDC Package Code
0049-0620-33
Package Description
10 AMPULE in 1 PACKAGE / 2.5 mL in 1 AMPULE
Product Code
0049-0620
11-Digit Billing Format
00049062033

Clinical Specifications

Proprietary Name
Streptomycin Sulfate
Dosage Form
-
Usage Information
This medication is used with other medications to treat active tuberculosis (TB) infection if you cannot take other drugs for TB or if you have a type of TB that cannot be treated with other drugs (drug-resistant TB). Streptomycin belongs to a class of drugs known as aminoglycoside antibiotics. It works by killing the organisms that cause the infection. This drug may also be used to treat other serious infections (e.g., Mycobacterium avium complex-MAC, tularemia, endocarditis, plague) along with other medications.

Regulatory & Marketing

Labeler Name
Roerig
FDA Application #
ANDA060111
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-01-1952
End Marketing Date
09-01-2001
Listing Expiration
09-01-2001
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0049-0620-33 identifies a specific commercial package of 10 ampule in 1 package / 2.5 ml in 1 ampule of Streptomycin Sulfate, labeled by Roerig. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Roerig on March 01, 1952. The current certification is valid through September 01, 2001.

What are the primary indications for this medication?

This medication is used with other medications to treat active tuberculosis (TB) infection if you cannot take other drugs for TB or if you have a type of TB that cannot be treated with other drugs (drug-resistant TB). Streptomycin belongs to a class of drugs known as aminoglycoside antibiotics. It works by killing the organisms that cause the infection. This drug may also be used to treat other serious infections (e.g., Mycobacterium avium complex-MAC, tularemia, endocarditis, plague) along with other medications.

How is this Roerig product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00049062033. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0049-0620-33
11-Digit CMS (5-4-2)
00049-0620-33

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.